Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hemophilia Market, by Distribution Channel
1.4.2 North America Hemophilia Market, by Type
1.4.3 North America Hemophilia Market, by Treatment Type
1.4.4 North America Hemophilia Market, by Therapy
1.4.5 North America Hemophilia Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. North America Hemophilia Market by Distribution Channel
5.1 North America Specialty Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
Chapter 6. North America Hemophilia Market by Type
6.1 North America Hemophilia A Market by Country
6.2 North America Hemophilia B Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Hemophilia Market by Treatment Type
7.1 North America Prophylaxis Market by Country
7.2 North America On-demand Market by Country
7.3 North America Cure Market by Country
Chapter 8. North America Hemophilia Market by Therapy
8.1 North America Factor Replacement Therapy Market by Country
8.2 North America Hemophilia Market by Factor Replacement Therapy Type
8.2.1 North America Recombinant Factor Concentrates Market by Country
8.2.2 North America Plasma-derived Factor Concentrates Market by Country
8.3 North America Desmopressin & Fibrin Sealants Market by Country
8.4 North America Gene Therapy & Monoclonal Antibodies Market by Country
Chapter 9. North America Hemophilia Market by Country
9.1 US Hemophilia Market
9.1.1 US Hemophilia Market by Distribution Channel
9.1.2 US Hemophilia Market by Type
9.1.3 US Hemophilia Market by Treatment Type
9.1.4 US Hemophilia Market by Therapy
9.1.4.1 US Hemophilia Market by Factor Replacement Therapy Type
9.2 Canada Hemophilia Market
9.2.1 Canada Hemophilia Market by Distribution Channel
9.2.2 Canada Hemophilia Market by Type
9.2.3 Canada Hemophilia Market by Treatment Type
9.2.4 Canada Hemophilia Market by Therapy
9.2.4.1 Canada Hemophilia Market by Factor Replacement Therapy Type
9.3 Mexico Hemophilia Market
9.3.1 Mexico Hemophilia Market by Distribution Channel
9.3.2 Mexico Hemophilia Market by Type
9.3.3 Mexico Hemophilia Market by Treatment Type
9.3.4 Mexico Hemophilia Market by Therapy
9.3.4.1 Mexico Hemophilia Market by Factor Replacement Therapy Type
9.4 Rest of North America Hemophilia Market
9.4.1 Rest of North America Hemophilia Market by Distribution Channel
9.4.2 Rest of North America Hemophilia Market by Type
9.4.3 Rest of North America Hemophilia Market by Treatment Type
9.4.4 Rest of North America Hemophilia Market by Therapy
9.4.4.1 Rest of North America Hemophilia Market by Factor Replacement Therapy Type
Chapter 10. Company Profiles
10.1 Swedish Orphan Biovitrum AB (Investor AB)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 SWOT Analysis
10.2 Takeda Pharmaceutical Company Limited
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Trials and Approvals:
10.2.5.2 Product Launches and Product Expansions:
10.3 Pfizer, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional & Segmental Analysis
10.3.4 Research & Development Expense
10.3.4.1 Partnerships, Collaborations, and Agreements:
10.3.4.2 Acquisition and Mergers:
10.4 CSL Limited (CSL Behring)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Trials and Approvals:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Octapharma AG
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Research & Development Expenses
10.5.4 Recent strategies and developments:
10.5.4.1 Trials and Approvals:
10.5.5 SWOT Analysis
10.6 Bayer AG
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.6.5.2 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 F. Hoffmann-La Roche Ltd.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 Novo Nordisk A/S
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental & Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Product Launches and Product Expansions:
10.8.5.3 Acquisition and Mergers:
10.8.6 SWOT Analysis
10.9 BioMarin Pharmaceutical Inc.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Trials and Approvals:
10.9.6 SWOT Analysis
10.10. Sanofi S.A.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Trials and Approvals:



List of Figures

FIG 1 Methodology for the research
FIG 2 North America Hemophilia Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Hemophilia Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 7 Porter’s Five Forces Analysis –Hemophilia Market
FIG 8 North America Hemophilia Market share by Distribution Channel, 2022
FIG 9 North America Hemophilia Market share by Distribution Channel, 2030
FIG 10 North America Hemophilia Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 North America Hemophilia Market share by Type, 2022
FIG 12 North America Hemophilia Market share by Type, 2030
FIG 13 North America Hemophilia Market by Type, 2019 - 2030, USD Million
FIG 14 North America Hemophilia Market share by Treatment Type, 2022
FIG 15 North America Hemophilia Market share by Treatment Type, 2030
FIG 16 North America Hemophilia Market by Treatment Type, 2019 - 2030, USD Million
FIG 17 North America Hemophilia Market share by Therapy, 2022
FIG 18 North America Hemophilia Market share by Therapy, 2030
FIG 19 North America Hemophilia Market by Therapy, 2019 - 2030, USD Million
FIG 20 North America Hemophilia Market share by Country, 2022
FIG 21 North America Hemophilia Market share by Country, 2030
FIG 22 North America Hemophilia Market by Country, 2019 - 2030, USD Million
FIG 23 SWOT Analysis: Swedish Orphan Biovitrum AB
FIG 24 SWOT Analysis: CSL Limited
FIG 25 SWOT Analysis: Octapharma AG
FIG 26 SWOT Analysis: Bayer AG
FIG 27 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 28 Recent strategies and developments: Novo Nordisk A/S
FIG 29 SWOT Analysis: Novo Nordisk A/S
FIG 30 SWOT Analysis: BioMarin Pharmaceutical Inc.

List of Tables

TABLE 1 North America Hemophilia Market, 2019 - 2022, USD Million
TABLE 2 North America Hemophilia Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Hemophilia Market
TABLE 4 Product Launches And Product Expansions– Hemophilia Market
TABLE 5 Acquisition and Mergers– Hemophilia Market
TABLE 6 Trials and Approvals– Hemophilia Market
TABLE 7 North America Hemophilia Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 8 North America Hemophilia Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 9 North America Specialty Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Specialty Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Hemophilia Market by Type, 2019 - 2022, USD Million
TABLE 14 North America Hemophilia Market by Type, 2023 - 2030, USD Million
TABLE 15 North America Hemophilia A Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Hemophilia A Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Hemophilia B Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Hemophilia B Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Hemophilia Market by Treatment Type, 2019 - 2022, USD Million
TABLE 22 North America Hemophilia Market by Treatment Type, 2023 - 2030, USD Million
TABLE 23 North America Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 25 North America On-demand Market by Country, 2019 - 2022, USD Million
TABLE 26 North America On-demand Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Cure Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Cure Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Hemophilia Market by Therapy, 2019 - 2022, USD Million
TABLE 30 North America Hemophilia Market by Therapy, 2023 - 2030, USD Million
TABLE 31 North America Factor Replacement Therapy Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Factor Replacement Therapy Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Hemophilia Market by Factor Replacement Therapy Type, 2019 - 2022, USD Million
TABLE 34 North America Hemophilia Market by Factor Replacement Therapy Type, 2023 - 2030, USD Million
TABLE 35 North America Recombinant Factor Concentrates Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Recombinant Factor Concentrates Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Plasma-derived Factor Concentrates Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Plasma-derived Factor Concentrates Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Desmopressin & Fibrin Sealants Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Desmopressin & Fibrin Sealants Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Gene Therapy & Monoclonal Antibodies?Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Gene Therapy & Monoclonal Antibodies?Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Hemophilia Market by Country, 2023 - 2030, USD Million
TABLE 45 US Hemophilia Market, 2019 - 2022, USD Million
TABLE 46 US Hemophilia Market, 2023 - 2030, USD Million
TABLE 47 US Hemophilia Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 48 US Hemophilia Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 49 US Hemophilia Market by Type, 2019 - 2022, USD Million
TABLE 50 US Hemophilia Market by Type, 2023 - 2030, USD Million
TABLE 51 US Hemophilia Market by Treatment Type, 2019 - 2022, USD Million
TABLE 52 US Hemophilia Market by Treatment Type, 2023 - 2030, USD Million
TABLE 53 US Hemophilia Market by Therapy, 2019 - 2022, USD Million
TABLE 54 US Hemophilia Market by Therapy, 2023 - 2030, USD Million
TABLE 55 US Hemophilia Market by Factor Replacement Therapy Type, 2019 - 2022, USD Million
TABLE 56 US Hemophilia Market by Factor Replacement Therapy Type, 2023 - 2030, USD Million
TABLE 57 Canada Hemophilia Market, 2019 - 2022, USD Million
TABLE 58 Canada Hemophilia Market, 2023 - 2030, USD Million
TABLE 59 Canada Hemophilia Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 Canada Hemophilia Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 61 Canada Hemophilia Market by Type, 2019 - 2022, USD Million
TABLE 62 Canada Hemophilia Market by Type, 2023 - 2030, USD Million
TABLE 63 Canada Hemophilia Market by Treatment Type, 2019 - 2022, USD Million
TABLE 64 Canada Hemophilia Market by Treatment Type, 2023 - 2030, USD Million
TABLE 65 Canada Hemophilia Market by Therapy, 2019 - 2022, USD Million
TABLE 66 Canada Hemophilia Market by Therapy, 2023 - 2030, USD Million
TABLE 67 Canada Hemophilia Market by Factor Replacement Therapy Type, 2019 - 2022, USD Million
TABLE 68 Canada Hemophilia Market by Factor Replacement Therapy Type, 2023 - 2030, USD Million
TABLE 69 Mexico Hemophilia Market, 2019 - 2022, USD Million
TABLE 70 Mexico Hemophilia Market, 2023 - 2030, USD Million
TABLE 71 Mexico Hemophilia Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 72 Mexico Hemophilia Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 73 Mexico Hemophilia Market by Type, 2019 - 2022, USD Million
TABLE 74 Mexico Hemophilia Market by Type, 2023 - 2030, USD Million
TABLE 75 Mexico Hemophilia Market by Treatment Type, 2019 - 2022, USD Million
TABLE 76 Mexico Hemophilia Market by Treatment Type, 2023 - 2030, USD Million
TABLE 77 Mexico Hemophilia Market by Therapy, 2019 - 2022, USD Million
TABLE 78 Mexico Hemophilia Market by Therapy, 2023 - 2030, USD Million
TABLE 79 Mexico Hemophilia Market by Factor Replacement Therapy Type, 2019 - 2022, USD Million
TABLE 80 Mexico Hemophilia Market by Factor Replacement Therapy Type, 2023 - 2030, USD Million
TABLE 81 Rest of North America Hemophilia Market, 2019 - 2022, USD Million
TABLE 82 Rest of North America Hemophilia Market, 2023 - 2030, USD Million
TABLE 83 Rest of North America Hemophilia Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Rest of North America Hemophilia Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Rest of North America Hemophilia Market by Type, 2019 - 2022, USD Million
TABLE 86 Rest of North America Hemophilia Market by Type, 2023 - 2030, USD Million
TABLE 87 Rest of North America Hemophilia Market by Treatment Type, 2019 - 2022, USD Million
TABLE 88 Rest of North America Hemophilia Market by Treatment Type, 2023 - 2030, USD Million
TABLE 89 Rest of North America Hemophilia Market by Therapy, 2019 - 2022, USD Million
TABLE 90 Rest of North America Hemophilia Market by Therapy, 2023 - 2030, USD Million
TABLE 91 Rest of North America Hemophilia Market by Factor Replacement Therapy Type, 2019 - 2022, USD Million
TABLE 92 Rest of North America Hemophilia Market by Factor Replacement Therapy Type, 2023 - 2030, USD Million
TABLE 93 Key Information – Swedish Orphan Biovitrum AB
TABLE 94 Key Information – Takeda Pharmaceutical Company Limited
TABLE 95 Key Information – Pfizer, Inc.
TABLE 96 Key Information – CSL Limited
TABLE 97 Key Information – Octapharma AG
TABLE 98 Key Information – Bayer AG
TABLE 99 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 100 Key Information – Novo Nordisk A/S
TABLE 101 Key Information – BioMarin Pharmaceutical Inc.
TABLE 102 Key Information – Sanofi S.A.